These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34275899)

  • 1. Associations Between Cognitive Complaints, Memory Performance, Mood, and Amyloid-β Accumulation in Healthy Amyloid Negative Late-Midlife Individuals.
    Narbutas J; Van Egroo M; Chylinski D; Bahri MA; Koshmanova E; Talwar P; Besson G; Muto V; Schmidt C; Luxen A; Balteau E; Phillips C; Maquet P; Salmon E; Bastin C; Vandewalle G; Collette F
    J Alzheimers Dis; 2021; 83(1):127-141. PubMed ID: 34275899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
    Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
    J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
    Doraiswamy PM; Sperling RA; Coleman RE; Johnson KA; Reiman EM; Davis MD; Grundman M; Sabbagh MN; Sadowsky CH; Fleisher AS; Carpenter A; Clark CM; Joshi AD; Mintun MA; Skovronsky DM; Pontecorvo MJ;
    Neurology; 2012 Oct; 79(16):1636-44. PubMed ID: 22786606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data.
    Amariglio RE; Sikkes SAM; Marshall GA; Buckley RF; Gatchel JR; Johnson KA; Rentz DM; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge KC; Sims JR; Grill JD; Aisen PS; Sperling RA
    J Prev Alzheimers Dis; 2021; 8(3):257-262. PubMed ID: 34101781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly.
    Vogel JW; Varga Doležalová M; La Joie R; Marks SM; Schwimmer HD; Landau SM; Jagust WJ
    Neurology; 2017 Nov; 89(19):2002-2009. PubMed ID: 28986416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects.
    Squarzoni P; Faria DP; Yassuda MS; Porto FHG; Coutinho AM; Costa NAD; Nitrini R; Forlenza OV; Duran FLS; Brucki SMD; Buchpiguel CA; Busatto GF
    J Alzheimers Dis; 2020; 78(1):229-244. PubMed ID: 32986673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.
    van Bergen JMG; Li X; Quevenco FC; Gietl AF; Treyer V; Meyer R; Buck A; Kaufmann PA; Nitsch RM; van Zijl PCM; Hock C; Unschuld PG
    Neuroimage; 2018 Jul; 174():308-316. PubMed ID: 29548847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults.
    Lindbergh CA; Casaletto KB; Staffaroni AM; La Joie R; Iaccarino L; Edwards L; Tsoy E; Elahi F; Walters SM; Cotter D; You M; Apple AC; Asken B; Neuhaus J; Rexach JE; Wojta KJ; Rabinovici G; Kramer JH;
    Neuropsychology; 2020 Nov; 34(8):835-850. PubMed ID: 33030915
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
    Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
    Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.
    Snitz BE; Weissfeld LA; Cohen AD; Lopez OL; Nebes RD; Aizenstein HJ; McDade E; Price JC; Mathis CA; Klunk WE
    Am J Geriatr Psychiatry; 2015 Sep; 23(9):985-93. PubMed ID: 25746485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory decline accompanies subthreshold amyloid accumulation.
    Landau SM; Horng A; Jagust WJ;
    Neurology; 2018 Apr; 90(17):e1452-e1460. PubMed ID: 29572282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.
    Farrell ME; Kennedy KM; Rodrigue KM; Wig G; Bischof GN; Rieck JR; Chen X; Festini SB; Devous MD; Park DC
    JAMA Neurol; 2017 Jul; 74(7):830-838. PubMed ID: 28558099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
    Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ
    Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.
    Pike KE; Ellis KA; Villemagne VL; Good N; Chételat G; Ames D; Szoeke C; Laws SM; Verdile G; Martins RN; Masters CL; Rowe CC
    Neuropsychologia; 2011 Jul; 49(9):2384-90. PubMed ID: 21529702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.